Drug Interaction Studies with Clinafloxacin and Probenecid, Cimetidine, Phenytoin and Warfarin

Randinitis, E.J.; Koup, J.R.; Bron, N.J.; Hounslow, N.J.; Rausch, G.; Abel, R.; Vassos, A.B.; Sedman, A.J.
December 1999
Drugs;Dec1999 Supplement 2, Vol. 58 Issue 6, p254
Academic Journal
Examines the potential for a pharmacodynamic effect of clinafloxacin on warfarin. Materials and methods; Results and discussion.


Related Articles

  • Should Aspirin be Continued in Patients Started on Warfarin? Larson, Robin J.; Fisher, Elliott S. // JGIM: Journal of General Internal Medicine;Aug2004, Vol. 19 Issue 8, p879 

    Clinicians frequently face the decision of whether to continue aspirin when starting patients on warfarin. We performed a meta-analysis to characterize the tradeoffs involved in this common clinical dilemma. Multiple computerized databases (1966 to 2003), reference lists of relevant articles,...

  • Drug interactions with warfarin: what clinicians need to know. Juurlink, David N. // CMAJ: Canadian Medical Association Journal;8/14/2007, Vol. 177 Issue 4, p369 

    The article focuses on the complications related to drug interactions with warfarin and discusses several useful tips that clinicians should keep in mind for their effective treatment. It is stated that majority of drug interactions result in an increased risk of hemorrhage and many of them are...

  • Verification of pharmacogenomics-based algorithms to predict warfarin maintenance dose using registered data of Japanese patients. Sasano, Maki; Ohno, Masako; Fukuda, Yuya; Nonen, Shinpei; Hirobe, Sachiko; Maeda, Shinichiro; Miwa, Yoshihiro; Yokoyama, Junya; Nakayama, Hiroyuki; Miyagawa, Shigeru; Sawa, Yoshiki; Fujio, Yasushi; Maeda, Makiko // European Journal of Clinical Pharmacology;Jul2019, Vol. 75 Issue 7, p901 

    Purpose: Large inter-individual differences in warfarin maintenance dose are mostly due to the effect of genetic polymorphisms in multiple genes, including vitamin K epoxide reductase complex 1 (VKORC1), cytochromes P450 2C9 (CYP2C9), and cytochrome P450 4F2 (CYP4F2). Thus, several algorithms...

  • Increased INR after brief warfarin. Hirsh, Jack // Patient Care;3/1/1998, Vol. 32 Issue 3, p14 

    Examines the impact of warfarin on the acceleration of the INR rates, while highlighting a case study of a 40 year old patient. Factors which should be considered on treating the patient; Possible causes of the acceleration of the INR rates.

  • Center is key to administering anticoagulant safely and easily. Morrissey, John // Modern Healthcare;12/19/94-12/26/94, Vol. 24 Issue 51, p58 

    Discusses the benefits offered by the monitoring centers set up for the warfarin program. Risks of too strong dose of warfarin, a drug that can prevent strokes and blood clots; Monitoring process for warfarin therapy; Concern over warfarin's potential to cause internal bleeding.

  • Warfarin widely underprescribed in patients with atrial fibrillation.  // Geriatrics;Mar98, Vol. 53 Issue 3, p18 

    Reports on a study regarding the drug Warfarin and its underprescription despite its effects on patients with atrial fibrillation. Details on atrial fibrillation; Benefits of Warfarin on treating this condition; Results of the study; Comments from Lawrence Brass, medical doctor.

  • Warfarin use improves survival in heart failure patients.  // Modern Medicine;Jun98, Vol. 66 Issue 6, p30 

    Presents an abstract of the article `Warfarin Anticoagulation and Survival: A Cohort Analysis from the Studies of Left Ventricular Dysfunction,' by A.S. Al-Khadra, D.N. Salem, et al from the `Journal of American College Cardiology,' dated March 15, 1998.

  • Creating a coumadin clinic. Hart, Dorothy F. // RN;Aug98, Vol. 61 Issue 8, p22 

    Discusses the formation of a `Coumadin Clinic' within the general medical clinic, after noticing the trend that patients who were taking warfarin were not keeping their regular medical appointments. Importance of regular blood draws to patients taking warfarin; Description of the level of...

  • Erratum to: Warfarin dose prediction in children using pharmacometric bridging - comparison with published pharmacogenetic dosing algorithms. Hamberg, Anna-Karin; Friberg, Lena; HansĂ©us, Katarina; Ekman-Joelsson, Britt-Marie; SunnegĂ„rdh, Jan; Jonzon, Anders; Lundell, Bo; Jonsson, E.; Wadelius, Mia // European Journal of Clinical Pharmacology;Sep2013, Vol. 69 Issue 9, p1737 

    A correction is presented for the article "Warfarin Dose Prediction in Children Using Pharmacometric Bridging: Comparison With Published Pharmacogenetic Dosing Algorithms" by Anna-Karin Hamberg et al.

  • Erratum:.  // Reactions Weekly;7/24/2010, Issue 1311, p45 

    A correction to the article "Warfarin: Pulmonary Haemorrhage," that was published in No. 1271 issue is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics